Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

As Moderna has significantly lagged behind the broader market over the past year, Wall Street analysts maintain a cautious ...

Currently trading with a volume of 3,803,131, the MRNA's price is down by -1.06%, now at $27.18. RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...

Research shows mRNA vaccines saved millions of lives during the COVID-19 pandemic. Now scientists are using that Nobel ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and ...

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...

The decision effectively cancels projects being led by major pharmaceutical companies, including Pfizer and Moderna.